Dataset Information


Somatic TP53 variants frequently confound germ-line testing results.

ABSTRACT: PURPOSE:Blood/saliva DNA is thought to represent the germ line in genetic cancer-risk assessment. Cases with pathogenic TP53 variants detected by multigene panel testing are often discordant with Li-Fraumeni syndrome, raising concern about misinterpretation of acquired aberrant clonal expansions (ACEs) with TP53 variants as germ-line results. METHODS:Pathogenic TP53 variants with abnormal next-generation sequencing metrics (e.g., decreased ratio (<25%) of mutant to wild-type allele, more than two detected alleles) were selected from a CLIA laboratory testing cohort. Alternate tissues and/or close relatives were tested to distinguish between ACE and germ-line status. Clinical data and Li-Fraumeni syndrome testing criteria were examined. RESULTS:Among 114,630 multigene panel tests and 1,454 TP53 gene-specific analyses, abnormal next-generation sequencing metrics were observed in 20% of 353 TP53-positive results, and ACE was confirmed for 91% of cases with ancillary materials, most of these due to clonal hematopoiesis. Only four met Chompret criteria. Individuals with ACE were older (50 years vs. 33.7; P?=?0.02) and were identified more frequently in multigene panel tests (66/285; 23.2%) than in TP53 gene-specific tests (6/68; 8.8%, P?=?0.005). CONCLUSION:ACE confounds germ-line diagnosis, may portend hematologic malignancy, and may provoke unwarranted clinical interventions. Ancillary testing to confirm germ-line status should precede Li-Fraumeni syndrome management.


PROVIDER: S-EPMC5976505 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5787862 | BioStudies
2018-01-01 | S-EPMC5811989 | BioStudies
2018-01-01 | S-EPMC6128690 | BioStudies
2009-01-01 | S-EPMC2806269 | BioStudies
2018-01-01 | S-EPMC6081832 | BioStudies
2015-01-01 | S-EPMC4465271 | BioStudies
2007-01-01 | S-EPMC2128783 | BioStudies
2020-01-01 | S-EPMC7106707 | BioStudies
2011-01-01 | S-EPMC4194062 | BioStudies
2016-01-01 | S-EPMC4925265 | BioStudies